RDN for CKD and Uncontrolled Hypertension Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 248 participants.

Also called NCT07945795

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 248 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07945795
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07945795. Randomized; single masking; primary purpose treatment. Start 2025-12-08 (actual); primary completion 2027-10-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
RDN for CKD and Uncontrolled Hypertension Trial
Condition
Hypertension
Intervention (Device)
Radiofrequency Renal Denervation System
Intervention (Procedure)
Parallel control
Lead sponsor
Beijing Anzhen Hospital (class: other)

Record details

Record id
cardio:ct-nct07945795
Content hash
9c63202f2265b3425be5969476794c3d7a8e429bd3897319ea82ebec5c3acbb5